Neustar DNS ShieldTM Network Securely Delivers High-speed Web Performance
Neustar, Inc. (NYSE: NSR), a trusted, neutral provider of real-time information services, today announced the public launch of its DNS ShieldTM, a worldwide network of secure private domain name system (DNS) connections between Neustar and its partners. Neustar’s DNS ShieldTM network is independent of public internet networks and embodies an industry-first approach to eliminating latency and security vulnerabilities for DNS traffic within its partner network.
“DNS is the backbone of the Internet, but the original protocol design was slightly flawed and failed to take in to account some of the potential security issues, which now make it an attractive target for attacks,” said Rodney Joffe, SVP and Distinguished Fellow, Neustar. “Optimizing and protecting DNS is a mission-critical task since an outage can result in downtime, network latency, lost revenue, and a negative brand experience.”
The recent emergence of the Mirai botnet, which compromised insecure Internet of Things (IoT) devices, created the perfect environment for massive DDoS attacks on DNS servers, which resulted in major Website outages. The DNS ShieldTM network forms a secure connection between Neustar UltraDNS authoritative servers and the recursive servers of its partners, minimizing the vulnerable points of compromise targeted in distributed denial of service (DDoS) attacks and DNS Spoofing, while lowering the latency of DNS transactions and improving the reliability of query responses significantly.
Neustar’s DNS ShieldTM network supplements a global IP Anycast Network by adding scores of private nodes to the existing 30 public nodes across six continents to answer more than 33 billion queries per day. The Neustar network already includes a purpose-built DDoS mitigation solution that protects its UltraDNS network, but the addition of the DNS ShieldTM network will harden its defenses against attacks by removing traffic entirely from the public Internet domain.
Key benefits and features of the DNS ShieldTM network include:
- Lower Latency – Delivers superior Website performance through its private DNS ShieldTM network, enabling DNS traffic to circumvent general public Internet networking connectivity that is frequently slow and congested, ensuring that even holiday traffic or massively scaling users cannot cause outages or delays. In most cases the DNS ShieldTM network nodes are located within 100 feet of partner recursive servers, reducing network latency to single digit milliseconds – the fastest in the world.
- Enhanced Security – The DNS ShieldTM network creates a private network for DNS resolution within its partner network, eliminating security threats, such as DDoS attacks and cache poisoning attempts by shielding direct DNS connections from public view and excluding public Internet traffic.
- Better Reliability – In the event of a DDoS attack or significant network outage, DNS queries will continue to resolve within the private networks where DNS ShieldTM technology is deployed. This resiliency ensures an optimal network experience for Neustar partners and customers to ensure maximum uptime.
“DNS remains constantly threatened by DDoS attacks, cache poisoning assaults, spoofing attempts, and innocently enough, high volume website traffic, which can all lead to service disruptions for a significant portion of the Internet,” said Joffe. “Neustar is hardwiring the Internet with private network connections between our authoritative servers and our partner’s recursive servers, limiting the potential for our UltraDNS network to succumb to these attacks.”
For more information about the Neustar DNS ShieldTM network, please visit https://hello.neustar.biz/2016-dns-shield-wp-security-lp.html
Every day, the world generates roughly 2.5 quadrillion bits of data. Neustar (NYSE: NSR) isolates certain elements and analyzes, simplifies and edits them to make precise and valuable decisions that drive results. As one of the few companies capable of knowing with certainty who is on the other end of every interaction, we’re trusted by the world’s great brands to make critical decisions some 20 billion times a day. We help marketers send timely and relevant messages to the right people. Because we can authoritatively tell a client exactly who is calling or connecting with them, we make critical real-time responses possible. And the same comprehensive information that enables our clients to direct and manage orders also stops attackers. We know when someone isn’t who they claim to be, which helps stop fraud and denial of service before they’re a problem. Because we’re also an experienced manager of some of the world’s most complex databases, we help clients control their online identity, registering and protecting their domain name, and routing traffic to the correct network address. By linking the most essential information with the people who depend on it, we provide more than 12,000 clients worldwide with decisions—not just data. More information is available at http://www.neustar.biz.
Clinton Karr, 415-590-4611
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
BearingPoint: How Firms Transform into Digital Superpowers22.2.2018 08:30 | Pressemelding
Digital disruption has left Europe’s leading companies struggling to sustain growth and competitive advantage. Groundbreaking new research reveals how European companies can learn from US digital superpowers to speed up adoption of business model innovation, drive new revenues and get greater value from their core business. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180222005241/en/ Diversifying business model Portfolio (Graphic: Business Wire) Today, firms that adopt a portfolio of business models which are asset light and include network effects are perceived by investors and the market as most likely to generate future growth. They therefore have a much higher market value in comparison to companies with traditional business models. Companies who diversified their business models improved their valuation in 2016 by 65% in comparison to those who maintained a mono-business model. Furthermore, between 2011-2016 they mana
Eli Global to Acquire Lead Generation Marketplace Finanzen22.2.2018 08:00 | Pressemelding
Eli Global LLC (“Eli”) today announced that an affiliate has entered into a definitive agreement to acquire finanzen.de AG and its subsidiaries (collectively, “Finanzen” or the “company”) from Blackfin Capital Partners (“Blackfin”) and Finanzen’s founders. Based in Berlin, Germany, Finanzen is the leading European online marketplace for retail customer leads in the finance and insurance sectors. The company connects lead generators such as online price comparison sites with lead buyers such as independent financial advisors and insurance agents. The company also acts as an online broker for certain insurance products. “Finanzen has done an impressive job creating a scalable technology platform poised to benefit from industry trends,” said George Luecke, global manager of Eli’s newly established insurance services portfolio and co-CEO of Global Bankers Insurance Group, which represents Eli’s life and annuity carrier division (“GBIG”). “We look forward to a long-term future with the comp
Ferring Pharmaceuticals and MSD Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Haemorrhage22.2.2018 06:00 | Pressemelding
Ferring Pharmaceuticals and MSD, known as Merck & Co., Inc., Kenilworth, N.J., U.S.A., through its MSD for Mothers initiative, today announced the completion of CHAMPION (Carbetocin Haemorrhage Prevention), a global clinical trial conducted by the Human Reproduction Program (HRP) at the World Health Organization (WHO). CHAMPION is investigating whether Ferring’s proprietary and heat-stable carbetocin could offer a new solution to prevent excessive bleeding after childbirth (postpartum haemorrhage or PPH).2,3 Involving nearly 30,000 women in 10 countries, it is the largest clinical trial ever conducted in PPH.2,3 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180221006496/en/ Each year, 14 million mothers are affected by PPH.4 As the leading direct cause of maternal mortality, 480,000 mothers died from PPH between 2003-09.1 Even when women survive, PPH can result in the need for serious medical interventions, including surgica
The Nippon Foundation: Project to Map Ocean Floor by 2030 Now Operational22.2.2018 05:00 | Pressemelding
The Nippon Foundation Chairman Yohei Sasakawa announced at a press conference today that The Nippon Foundation – GEBCO Seabed 2030 Project is now operational. The Project will realize Mr. Sasakawa’s vision of mapping the entire ocean floor by 2030. The Nippon Foundation has pledged US$2 million annually, and is calling for additional support from the global ocean community. Mr. Sasakawa noted, “The Nippon Foundation alone cannot achieve the objectives of this ambitious project. We will need the support of diverse stakeholders, including maritime corporations and technical experts. It is crucial that the ocean community comes together to achieve this goal”. He was joined by leading ocean-mapping experts, who emphasized that understanding the bathymetry of the global ocean is imperative for improving maritime navigation, and also for enhancing our ability to predict climate change and monitor marine biodiversity and resources. A comprehensive map of the seafloor will assist global effort
Vertex Initiates First Phase 3 Study of VX-659, Tezacaftor and Ivacaftor as a Triple Combination Regimen for People with Cystic Fibrosis21.2.2018 21:01 | Pressemelding
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it is initiating the first Phase 3 study of VX-659, tezacaftor and ivacaftor as an investigational triple combination regimen for people with cystic fibrosis (CF) who have one F508del mutation and one minimal function mutation. The study will enroll 360 patients, and the primary endpoint of the study is the mean absolute change from baseline in percent predicted forced expiratory volume in one second (ppFEV1) at week four of treatment. The study is designed to support the submission of a New Drug Application (NDA) in the U.S. using data from the 4-week primary efficacy endpoint together with safety data through 12 weeks of treatment. “Our goal is to bring the best triple combination to patients as rapidly as possible, and this first Phase 3 study of VX-659 in combination with tezacaftor and ivacaftor is a significant step toward that goal,” said Jeffrey Chodakewitz, M.D., Executive Vice President and Chief Medical
Universal Laser Systems® Expands Portfolio of Laser Material Processing Systems with the ULTRA Platform Series21.2.2018 18:00 | Pressemelding
ULTRA platform-based laser systems are designed and ideally suited for precision laser cutting, laser ablation, and laser surface modification in manufacturing, research and development, academic research and prototyping environments. Major features of the series include rapid, high-accuracy laser beam positioning, and the flexibility to be configured with 9.3 and 10.6 µm CO2 lasers and 1.06 µm fiber lasers. All lasers are air-cooled in a range of power from 10 to 150 watts for CO2 and 40 to 50 watts for fiber lasers. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180221005364/en/ The ULTRA 9MW offers MultiWave processing of thin materials. (Photo: Business Wire) The variety of wavelengths and power ranges make the ULTRA platforms highly effective in the areas of organic material modification, including plastic films, industrial fabrics, engineering plastics, laminating adhesives, composite materials, and many others utilized